Abstract
The aim of this paper is to compare the effect of nebulized magnesium sulfate to nebulized salbutamol and salbutamol/magnesium sulfate on successful discharge from the emergency department. A total of 56 infants were included in this double-blinded, prospective study. Infants were grouped according to the nebulized treatment they received: group 1—salbutamol/normal saline, group 2—magnesium sulfate and normal saline, and group 3—salbutamol plus magnesium sulfate. Heart beat, bronchiolitis, clinical severity scores (CSS), and oxygen saturation of the patients were determined before and after nebulization (0, 1, 4 h). The patients were monitored for adverse reactions. Post-treatment mean CSS results were significantly lower than pre-treatment scores in all groups at 4 h with no significant difference within groups. CSS scores were lower in the salbutamol/magnesium sulfate group when compared with the magnesium sulfate and salbutamol groups (3.4 (2.4–4.3), 4.7 (3.8–5.7), 4.0 (3.2–4.3)). CSS were significantly lower than those from the magnesium sulfate group. Conclusion: Nebulized magnesium sulfate plus salbutamol may have additive effects for improving the short-term CSS.
Similar content being viewed by others
Abbreviations
- CSS:
-
Clinical severity scores
- SaO2 :
-
Oxygen saturation
References
Angat HS, D’Souza GA, Jacob MS (1998) Nebulized magnesium sulfate versus nebulized salbutamol in acute bronchial asthma, a clinical trial. Eur Respir J 12:341–344
Blitz M, Blitz S, Hughes R et al (2005) Aerosolized magnesium sulfate for acute asthma: a systematic review. Chest 128:337–344
Brunner EH, Delabroise AM, Haddad ZH (1985) Effect of parenteral magnesium on pulmonary function, plasma cAMP and histamine in bronchial asthma. J Asthma 22:3–11
Dominguez LJ, Barbagallo M, Di-Lorenzo G, Drago A, Scola S, Morici G, Caruso C (1998) Bronchial reactivity and intracellular magnesium: a possible mechanism for the bronchodilating effects of magnesium in asthma. Clin Sci 95:137–142
Gadomski AM, Brower M. (2010) Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. CD001266. Doi: 10.1002/14651858.
Hughes R, Goldkorn A, Masoli M, Weatherall M, Burgess C, Beasley R (2003) Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomized placebo-controlled trial. Lancet 361:2114–2117
Iseri LT, French JH (1984) Magnesium: nature’s physiologic calcium blocker. Am Heart J 108:188–193
Kao MC, Jan WC, Tsai PS, Wang TY, Huang CJ (2011) Magnesium sulfate mitigates lung injury induced by bilateral lower limb ischemia-reperfusion in rats. J Surg Res 171:e97–e106
Lee CY, Jan WC, Tsai PS, Huang CJ (2011) Magnesium sulfate mitigates acute lung injury in endotoxemia rats. J Trauma 70:1177–1185
Mathew R, Altura BM (1988) Magnesium and the lungs. Magnesium 7:173–187
Meral A, Coker M, Tanac R (1996) Inhalation therapy with magnesium sulfate in bronchial asthma. Turk J Pediatr 38:169–175
Plaisance P, Hibon A, Adnet F et al (1994) Potentiation of beta 2 agonists by inhaled magnesium sulfate in prehospital management of acute bronchial asthma. A double blind study. Am J Respir Crit Care Med 149:A40
Powell C, Dwan K, Milan SJ et al (2012) Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev 12, CD003898. doi:10.1002/14651858
Rolla G, Bucca C, Caria E (1988) Dose-related effect of inhaled MgSO4 on histamine bronchial challenge in asthmatics. Exp Clin Res 14:609–612
Wang EE, Milner RA, Navas L, Maj H (1992) Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis 145:106–109
Zorc JJ, Hall CB (2010) Bronchiolitis: recent evidence on diagnosis and management. Pediatrics 125:342–349
Conflict of interest
None of the authors have conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Peter de Winter
Rights and permissions
About this article
Cite this article
Kose, M., Ozturk, M.A., Poyrazoğlu, H. et al. The efficacy of nebulized salbutamol, magnesium sulfate, and salbutamol/magnesium sulfate combination in moderate bronchiolitis. Eur J Pediatr 173, 1157–1160 (2014). https://doi.org/10.1007/s00431-014-2309-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-014-2309-3